Citation Impact
Citing Papers
Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional Radiology
2013
Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model
2003
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
2002
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
2012
Hepatocellular carcinoma
2003 Standout
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
1990 Standout
Abdominal MR: liver and pancreas
1999
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective
2002
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension
2007
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
2016
Portal hypertension and variceal bleeding: An AASLD single topic symposium†
1998
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
2003
Random-effects model for meta-analysis of clinical trials: An update
2006 Standout
Hepatocellular carcinoma
2012 Standout
Image-Guided Ablation for Hepatocellular Carcinoma
2012
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Image-guided ablation of primary liver and renal tumours
2015
Portal Hypertensive Gastropathy and Colopathy
2014
Expanding consensus in portal hypertension
2015 Standout
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
2014
The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology
2015 Standout
A Controlled Study of Ranitidine for the Prevention of Recurrent Hemorrhage from Duodenal Ulcer
1994
Management of Hepatocellular Carcinoma *
2005 Standout
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
2010
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial
2004
Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation
2005
Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh score
2005
Liver cancer: Approaching a personalized care
2015
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
2005
Percutaneous Treatment of Hepatic Neoplasms: A Review of Current Techniques
1998
Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients
2005
Treatment of hepatocellular carcinoma in patients with cirrhosis
1997
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group
2014
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre
2005
Loco‐regional treatment of hepatocellular carcinoma†
2010
Management of Patients With Ulcer Bleeding
2012 Standout
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Global burden of liver disease: 2023 update
2023 Standout
Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience
1997
Management of HCC
2012
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
2010 Standout
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate
1998
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
2011
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014
Bleeding Peptic Ulcer
1994 Standout
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
2018 Standout
Ranitidine and cimetidine in the healing of duodenal ulcer: meta‐analysis of comparative clinical trials
1987
Small Hepatocellular Carcinoma in Cirrhosis: Randomized Comparison of Radio-frequency Thermal Ablation versus Percutaneous Ethanol Injection
2003
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients
1997
Hepatocellular Carcinoma
2011 Standout
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study
2020
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Hepatocellular Carcinoma
2019 Standout
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
2017
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
2015
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Comparison of Percutaneous Acetic Acid Injection and Percutaneous Ethanol Injection for Hepatocellular Carcinoma in Cirrhotic Patients: A Prospective Study
2003
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Thermal Ablation Therapy for Focal Malignancy
2000 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative Trial
1984
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Increased prevalence of intestinal inflammation in patients with liver cirrhosis
1999
Review article: overview of medical treatments in unresectable hepatocellular carcinoma—an impossible meta‐analysis?
1998
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of A Capria being referenced
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 western patients
1995
Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
2011
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C
2010
Colonic Disease in Cirrhotic Patients With Portal Hypertension
1998
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
1995
Clinical relevance of colonic lesions in cirrhotic patients with portal hypertension
2006
Comparison between ranitidine and cimetidine in the short-term treatment of duodenal ulcer.
1985
Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club.
1997
Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience.
1983
The long-term treatment of peptic ulcer after a bleeding episode.
1987
Entecavir for hepatitis B virus flare treatment in patients with Crohn's disease.
2010